31
Views
10
CrossRef citations to date
0
Altmetric
Case report

Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole

, , , , &
Pages 91-95 | Received 15 Jun 2003, Accepted 05 Jul 2004, Published online: 09 Jul 2009

References

  • Campbell CK, Al-Hedaithy SSA. Phaeohyphomycosis of the brain caused by Ramichloridium mackenziei sp. nov. in Middle Eastern countries. J Med Vet Mycol 1993; 31: 325–332.
  • Naim UR, Mahgoub ES, Chagla AH. Fatal brain abscesses caused by Ramichloridium obovoideum: report of three cases. Acta Neurochir (Wien) 1988; 93: 92–95.
  • Sutton DA, Slifkin M, Yakulis R, Rinaldi MG. US case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. rnackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa. J Gin Microbiol 1998; 36: 708–715.
  • Podnos YD, Anastasio P, De La ML, Kim RB. Cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (Ra-michloridium mackenziei): case report. Neurosurgery 1999; 45: 372–375.
  • Kanj SS, Amr SS, Roberts GD. Ramichloridium mackenziei brain abscess: report of two cases and review of the literature. Med Mycol 2001; 39: 97–102.
  • Kashgari TQ, Al-Miniawi H, Moawad Hanna MK. Cerebral phaeohyphomycosis caused by Ramichloridium mackenziei in the eastern province of Saudi Arabia. Ann Saudi Med 2000; 20: 457–460.
  • Khan ZU, Lamdhade SJ, Johny M, et al. Additional case of Ramichloridium mackenziei cerebral phaeohyphomycosis from the Middle East. Med Mycol 2002; 40: 429–433.
  • Dixon DM, Walsh TJ, Metz WG, McGinnis MR. Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis 1989; 11: 515–525.
  • Matsumoto T, Matsuda T, McGinnis MR, Ajello L. Clinical and mycological spectra of wangiella dermatitidis infections. Mycoses 1993; 36: 145–155.
  • Rinaldi MG, Inderlied CV, Mahnovski V, et al . Fatal Chaetomium atrobrunneum Ames, 1949, systemic mycoses in a patient with acute lymphoblastic leukemia. Presented at the XI Congress of the International Society for Human and Animal Mycology, Mon-treal, Canada, 1991.
  • Guppy KH, Thomas C, Thomas K, Anderson D. Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen — Chaetomium atrobrunneum: case report. Neurosurgery 1998; 43: 1463–1469.
  • Al Abdely HM, Najvar L, Bocanegra R, et al. SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum (Ramichloridium mackenziei). Ant imicrob Agents Chemother 2000; 44: 1159–1162.
  • National Committee for Clinical Laboratory Standards (NCCLS). Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: proposed standard M38P. 1998; M38P.
  • Al-Abdely H, Najvar L, Bocanegra R, Graybill JR. SCH-56592 (SCH) therapy of experimental murine cerebral phaeohyphomy-cosis due to Cladophialophora bantiana (CB). Presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, USA, 1998.
  • Mellinghoff 1K, Winston DJ, Mukwaya G, Schiller GJ. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis 2002; 34: 1648–1650.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.